WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry.
The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable.
“The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release.
Police raid the headquarters of the Milan
Dubai rain: Why experts don't think cloud seeding played a role
Tennessee judge wants more information on copyright before ruling on school shooter's writings
Megan Thee Stallion, Patricia Arquette, and Busy Philipps lead the pro
Bell's RBI single in 10th lifts Marlins to 3
NFL draft sees trend of fewer early entrants since NIL policy change
Brittany Mahomes pays tribute to 'hotttttt' husband Patrick amid dad
Lockdown lifts at Grand Forks Air Force Base in North Dakota after report of a single gunshot
Closing prices for crude oil, gold and other commodities
Charges dropped against suspect in 2016 cold case slaying of Tulane graduate
New York's high court upholds requiring insurance to cover medically necessary abortions
Brittany Mahomes pays tribute to 'hotttttt' husband Patrick amid dad